S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)

Acer Therapeutics (ACER) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
uk.finance.yahoo.com logoZevra Therapeutics Inc (ZVRA) Earnings: A Mixed Bag Against Analyst Estimates with Significant ...
uk.finance.yahoo.com - March 28 at 7:37 PM
msn.com logoHow to score 50% off The Legend of Zelda: Breath of the Wild
msn.com - February 22 at 10:32 AM
benzinga.com logoAcer Therapeutics Inc Stock (OTC:ACER), Guidance and Forecast
benzinga.com - January 6 at 3:15 AM
benzinga.com logoAcer Therapeutics Inc Stock (OTC:ACER) Dividends: History, Yield and Dates
benzinga.com - January 6 at 3:15 AM
finance.yahoo.com logoZevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer
finance.yahoo.com - January 4 at 10:09 AM
morningstar.com logoRelief Therapeutics Holding SA RLF
morningstar.com - December 31 at 12:02 AM
benzinga.com logoAcer Therapeutics Stock (NASDAQ:ACER) Insider Trades
benzinga.com - November 18 at 7:45 AM
markets.businessinsider.com logoZevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results
markets.businessinsider.com - November 7 at 8:31 AM
finance.yahoo.com logoZevra Therapeutics Inc (ZVRA) Reports Q3 2023 Financial Results
finance.yahoo.com - November 7 at 8:31 AM
finance.yahoo.com logoLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
finance.yahoo.com - November 2 at 9:00 AM
sg.finance.yahoo.com logoAcer Therapeutics Inc. (ACER)
sg.finance.yahoo.com - November 1 at 2:14 PM
247wallst.com logoHC Wainwright Downgrades Acer Therapeutics
247wallst.com - September 6 at 4:35 PM
247wallst.com logoRoth MKM Downgrades Acer Therapeutics
247wallst.com - September 5 at 8:50 PM
msn.com logoZevra's Rare Find: Unearthing Value In Niche Rare Diseases The Market Overlooks
msn.com - September 5 at 3:45 AM
msn.com logoRoth Capital Downgrades Acer Therapeutics (ACER)
msn.com - September 2 at 5:10 PM
msn.com logoRoth MKM Downgrades Acer Therapeutics (ACER)
msn.com - September 2 at 6:48 AM
msn.com logoAcer (ACER) to Get Acquired by Zevra for $91M, Stock Up
msn.com - September 1 at 10:43 AM
msn.com logoAcer Therapeutics will reacquire OLPRUVA rights from Relief Therapeutics
msn.com - September 1 at 5:42 AM
marketwatch.com logoZevra Therapeutics to Buy Acer Therapeutics >ZVRA ACER
marketwatch.com - August 31 at 7:41 PM
markets.businessinsider.com logoUS Stocks Rise; Initial Jobless Claims Edge Lower
markets.businessinsider.com - August 31 at 2:41 PM
msn.com logoWhy Is Acer Therapeutics Stock Trading Higher Today?
msn.com - August 31 at 2:41 PM
technews.tmcnet.com logoACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders
technews.tmcnet.com - August 31 at 2:41 PM
marketwatch.com logoAcer Therapeutics Shares Take Flight on Zevra Deal
marketwatch.com - August 31 at 2:41 PM
seekingalpha.com logoAcer Therapeutics surges as Zevra agrees to acquire for up to $91M
seekingalpha.com - August 31 at 2:41 PM
msn.com logoZerva acquires Acer Therapeutics to bolster rare disease portfolio
msn.com - August 31 at 2:41 PM
msn.com logoAcer Therapeutics (NASDAQ:ACER) Skyrockets on Acquisition by Zevra Therapeutics
msn.com - August 31 at 2:41 PM
finance.yahoo.com logoZevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
finance.yahoo.com - August 31 at 2:41 PM
finance.yahoo.com logoStruggling Newton biotech Acer Therapeutics scooped up by Florida firm
finance.yahoo.com - August 31 at 2:41 PM
marketbeat.com logo
marketbeat.com - August 31 at 9:54 AM
marketbeat.com logo
marketbeat.com - August 31 at 9:49 AM
markets.businessinsider.com logoRelief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA (ACER-001) with Acer Therapeutics
markets.businessinsider.com - August 30 at 6:59 PM
finance.yahoo.com logoAcer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
finance.yahoo.com - August 30 at 6:59 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 16 at 4:44 AM
finance.yahoo.com logoAcer Therapeutics, funded almost entirely by its own CEO, has weeks to live
finance.yahoo.com - August 15 at 6:43 PM
msn.com logoAcer Therapeutics GAAP EPS of -$0.33
msn.com - August 14 at 9:27 PM
finance.yahoo.com logoAcer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 14 at 4:27 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
finanznachrichten.de - June 26 at 2:06 PM
seekingalpha.com logoAcer Therapeutics CEO infuses $1M into company in exchange for promissory note
seekingalpha.com - June 26 at 2:06 PM
finance.yahoo.com logoAcer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
finance.yahoo.com - June 26 at 9:06 AM
finance.yahoo.com logoACER - Acer Therapeutics Inc.
finance.yahoo.com - June 10 at 11:46 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - May 16 at 8:24 AM
finance.yahoo.com logoAcer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - May 15 at 8:55 PM
marketwatch.com logoAcer Therapeutics Announces OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
marketwatch.com - May 2 at 9:52 AM
markets.businessinsider.com logoRelief Therapeutics Announces Collaboration Partner Reports OLPRUVA Commercial Launch Progressing Ahead of Schedule
markets.businessinsider.com - May 1 at 9:07 AM
finance.yahoo.com logoAcer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
finance.yahoo.com - May 1 at 9:07 AM
markets.businessinsider.com logoRelief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
markets.businessinsider.com - April 14 at 1:44 AM
finance.yahoo.com logoAcer Therapeutics Inc. (ACER) Gains But Lags Market: What You Should Know
finance.yahoo.com - March 31 at 8:11 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - March 29 at 5:59 PM
finance.yahoo.com logoAcer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - March 27 at 8:27 PM
finanznachrichten.de logoAcer Therapeutics Inc.: Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finanznachrichten.de - March 22 at 3:35 PM
Get Acer Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.

Here’s how to start a “Weekend Side Hustle” from your sofa (Ad)

Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.

Weekend after weekend!

ACER Media Mentions By Week

ACER Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACER
News Sentiment

-0.35

0.52

Average
Medical
News Sentiment

ACER News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACER Articles
This Week

0

0

ACER Articles
Average Week

Get Acer Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ACER) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners